Important Safety Information | NIOX VERO® User Manual (PDF)

For Healthcare Professionals Only

EN

Distributors

White Papers

Summary of Evidence Supporting the Clinical Value of Monitoring Exhaled Nitric

Why use FeNO for asthma diagnosis and routine management?
A NIOX® White Paper - March 2022

This white paper summarizes current evidence supporting the use of fractional exhaled nitric oxide (FeNO) to aid in the initial diagnosis and routine management of asthma. The clinical benefits of measuring and monitoring FeNO in asthma are well recognized and FeNO testing is currently recommended by all key international and national asthma guidelines.